Rybelsus and Depression are not formally linked in the FDA prescribing information. However, depressive symptoms following the use of the novel GLP-1 agonist, Semaglutide, are being frequently reported.
We reviewed different Semaglutide discussion groups on social media forums to find the association and burden of depressive symptoms in patients who have been prescribed Rybelsus.
Unlike Ozempic and Wegovy, Rybelsus is administered as an oral pill, and hence, the symptoms of anxiety associated with injections (and needles) are not an issue with Rybelsus.
How Patients on Rybelsus Describe Depressive Symptoms:
Patients who were on Rybelsus described their symptoms on social media discussion forums as:
- frustrated or going crazy
- helpless and not optimistic
- in denial and being angry
- Still, fingers crossed and waiting
- The medicines are so repulsive to me
- These medicines are counterproductive
- I can not concentrate on my diet
- I am having a very rough time
- I am having a persistent headache
- I can not sleep because of palpitations
- I have a dry mouth and palpitations
Since these were the symptoms as described by the patients, they are not in accordance with the DSM-5 criteria of depression.
The DSM-5 Criteria of depression include any five of the following symptoms over a period of at least two weeks.
- Low mood most of the day, almost every day
- Loss of interest in most activities of daily life almost every day
- Significant weight loss or weight gain without any change in diet
- Reduction in physical activities and slowdown of thoughts as observed by relatives or friends
- Fatigue and loss of energy
- A feeling of being worthless and feeling guilty
- Inability to think, concentrate, and decide
- thoughts of death, suicidal ideas
Five of the above symptoms, with at least one symptom as “low mood” and “loss of interest,” fulfill the diagnosis of depression.
Rybelsus and Depression: Can we link the two conditions?
As mentioned above, people on Rybelsus have symptoms that might correspond to the symptoms of depression.
There haven’t been enough studies to determine the association of depression with the use of Rybelsus.
One study found an improvement in the quality of life in patients who were being treated with Semaglutide. It was also noted that the quality of life improved most in the following patients [Ref]:
- Patients who achieved a weight loss of at least 5% or more,
- Patients whose A1C dropped by at least 1% or more,
- Patients who had minimal gastrointestinal side effects,
- Those who did not develop any major adverse cardiovascular outcomes (MACE), and
- Patients who did not develop hypoglycemia
Based on the above observations, the following groups of patients are at risk of developing depression and anxiety when using Rybelsus:
Intolerant Side effects:
When patients are switching from one kind of diabetes treatment to another, they are usually doing it either to overcome the side effects of the previous medicines, or they need better control of their diabetes.
However, Rybelsus is associated with frequent gastrointestinal side effects. Most patients switch or discontinue metformin because of the same side effects.
Experiencing the same side effects with Rybelsus triggers the symptoms of anxiety and stress.
Some patients may develop serious side effects such as MACE (major adverse cardiovascular events), pancreatitis, or thyroid malignancies. These patients can develop depression due to these illnesses.
Failure to achieve blood sugar targets:
As mentioned above, one of the reasons people switch to Rybelsus is because of uncontrolled blood glucose.
The A1C reduction observed in clinical trials ranged between 1 to 2% with both Rybelsus and metformin.
In one study, the mean HbA1C reduction with metformin was 1.2% after one year (from the baseline A1C of 8.1%) [Ref].
The A1C reduction with Rybelsus ranges between 0.8 to 1.3%. Thus, patients with uncontrolled blood glucose, when switched to Rybelsus, may observe no significant change in their glucose control.
This could be a reason for anxiety and hopelessness in patients. Such patients might get better results with the addition of metformin twice daily or metformin XR once daily at night.
Adding medicines increases the pill burden and the side effects, resulting in anxiety and depression.
Failure to lose weight with Rybelsus:
One of the reasons patients might switch to Rybelsus is to lose weight. However, it is important to note that Rybelsus is not approved as a weight-loss medicine.
Although the weight loss effects of Rybelsus have been observed to be greater than metformin and Januvia, and equivalent to Jardiance and Liraglutide (Saxenda), some patients might not lose enough weight as per their expectations.
This could lead to symptoms of anxiety and depression.
Hypoglycemia:
It has been noted that patients who develop frequent hypoglycemia are more prone to have symptoms of anxiety and depression.
Rybelsus can cause hypoglycemia when added to insulin or sulfonylureas. Symptoms of hypoglycemia may mimic a panic attack.
Patients who develop frequent episodes of hypoglycemia have palpitations, cold sweats, and apprehension.
Switching to a new, so-called more potent medicine might increase their fear of developing more severe hypoglycemia.
It is important to start with a low dose, i.e., 3 mg once daily, and then titrate the dose gradually. In addition, the dose of other diabetes medicines may need to be reduced to avoid hypoglycemia.
Increase in heart rate with Rybelsus:
In clinical trials, one of the side effects of Rybelsus was tachycardia or increased heart rate. It was observed to be more common in patients who were taking Rybelsus compared to placebo.
The heart rate in patients taking Rybelsus increased by 2 to 4 beats per minute compared with the placebo. Since tachycardia and palpitations are symptoms of anxiety, patients may attribute these symptoms to anxiety.
This is especially true for patients who have markedly increased heart rates.
To Summarize:
Rybelsus and depression are not formally linked, however, the association may be clinically relevant in a subset of patients who fail to achieve adequate glycemic control, do not lose the expected weight, or develop drug-induced side effects.
- Premium Ingredients: Our tea blend features high-quality Berberine, aromatic Oolong, and refreshing Mint, all organicall…
- Mint Flavored: Enjoy the cool, crisp taste of mint that perfectly complements the robust flavors of Berberine and Oolong…
- Unsweetened with Zero Calories: Crafted for those who appreciate the natural flavors of tea, our blend is completely uns…
- Health Benefits – Anxie-T supports the body’s natural ability to deal with common symptoms of stress, including nervousn…
- Clinically Tested Ingredients – Crafted with all natural ingredients such as Ashwagandha, Kava kava, L-theanine, and The…
- Effective – Most people experience the relaxing effects of Anxie-T the first day they take it, often within 30 minutes. …

- [Joy-Filled: Calm A Worried Mind] Feel more in control of your life & don’t let worries and tension get in the way. Our …
- [Mood Booster for Women & Men] Our ayurveda products can be the mood enhancer you’re looking for. Our adaptogens formula…
- [7 Natural Herbs] Formulated with 7 healing herbs, our powerful mood support pills are designed to help with stress. Mad…

- Natural Organic Non-GMO Plant-Based Herbs
- 7 Powerful Organic Herbs: 7 natural herbs have been used for centuries. These herbs are Gotu Kola Herb, Rhodiola Root, S…
- The herbs included have many well known benefits

- Manages occasional Anxiousness & Stress: Are there days you find it hard to function because you feel overwhelmed? or fe…
- Powerful 28 in 1 Supplement: Doctor formulated with 28 powerful natural herbs that are scientifically proven mood enhanc…
- People Over Profits: Unlike other calm mood support supplements, our product aims to increase sleep & mood support twice…
